A protein first identified by its association with cadherin cell adhesion molecules, ␤-catenin, has been implicated in carcinogenesis. In a number of different types of cancer, signalling through ␤-catenin is upregulated either by direct mutation of ␤-catenin or loss of negative regulation by the APC tumor suppressor protein.
The discovery of the adenomatous polyposis coli (APC) tumor suppressor gene was a major breakthrough for understanding the genesis of colorectal cancer [1] . Mutations in this gene not only lead to the development of familial colon cancer, but also are associated with the vast majority of cases of sporadic colorectal cancer. The predicted amino acid sequence of the ~300 kD protein encoded by the APC gene revealed little about its possible cellular function. However, a search for interacting proteins turned up an important lead: it associates in the cytoplasm with ␤-catenin, a polypeptide that binds to the cytoplasmic domain of the cadherin cell adhesion molecules and is required for effective cell-cell adhesion [2, 3] .
Because of the established function of ␤-catenin in cadherin-mediated cell adhesion, it was proposed initially that APC mutations contribute to the development of colon cancer because of their effects on intestinal cell adhesion and migration, processes important for the continual renewal of the intestinal lining. It has become clear, however, that ␤-catenin has a second role in the cell, as a mediator of signal transduction events that alter gene expression during important developmental processes [4, 5] . Indeed, several recent papers [6] [7] [8] have now reported that activation of ␤-catenin signaling, either by APC inactivation or mutations in ␤-catenin, plays a key role in both colon cancer and melanoma. Moreover, APC has been found to regulate ␤-catenin-mediated changes in gene transcription. Although it remains possible that APC has a role in cell adhesion and cell migration in the colon [9] , these findings provide an even more compelling model for the role of APC in carcinogenesis.
The ␤-catenin protein and its Drosophila homologue, Armadillo, are required for the transduction of signals initiated by Wnt growth factors (Wingless in Drosophila) [4, 5, 10] . Armadillo is a segment polarity gene important for the anteroposterior patterning of the cuticle during Drosophila embryogenesis. In Xenopus, ␤-catenin is required for an early step in the induction of the dorsal-ventral and anterior-posterior axes of the embryo. The overall organization of the Wingless and Wnt pathways in these two species is remarkably similar, involving many of the same components all along the pathway (Figure 1) .
A key component in both Wingless and Wnt pathways is the serine/threonine kinase known as glycogen synthase kinase (GSK) in vertebrates, or Zeste-white-3 or Shaggy in Drosophila, which inhibits downstream signal transduction through ␤-catenin. Curiously, in Xenopus it is still uncertain whether Wnt and the initial receptor-mediated events -which act via the receptor Frizzled and Dishevelledare actually involved in normal development, even though they can induce body axis formation [11, 12] . Instead, one of the more downstream components of the pathway may be activated by cytoplasmic rearrangements during the cortical rotation that is a very early event following fertilization of the egg. Nevertheless, the entire Wnt pathway is functional in Xenopus and it is remarkably similar to the Wingless pathway in Drosophila.
Cadherins and cell adhesion do not seem to be directly involved in signal transduction by ␤-catenin. Several experiments using various mutant forms of ␤-catenin and Armadillo have shown that their adhesion and signal transducing functions are separable [5, 13] . Cadherins can, however, act upstream of ␤-catenin to regulate its signaling activity [13, 14] . Sequestration of ␤-catenin to the membrane by binding to overexpressed cadherin strongly inhibits its signaling activity in both Xenopus and Drosophila. In some circumstances, therefore, cadherins and/or cell adhesion changes might control the signaling activity of ␤-catenin in parallel to, or instead of, Wnt receptor activity.
An important breakthrough for understanding the mechanism of signal transduction by ␤-catenin and Armadillo came with the discovery that they act through an interaction with a transcription factor called leukocyte enhancing factor 1 (LEF-1) or T-cell factor (TCF). In Xenopus, TCF/LEF has been implicated in induction of the dorsal-ventral and anterior-posterior body axes by Wnt and ␤-catenin [15, 16] . A strong candidate for a target gene for TCF/LEF in Xenopus is siamois, whose expression is directly induced by Wnt and ␤-catenin and which itself induces axis formation [17, 18] .
In Drosophila, the TCF/LEF homologue was identified in a genetic screen for wingless-like phenotype as a gene called pangolin, and shown to be required downstream of armadillo in Wingless signaling [19] [20] [21] . For the part wingless plays in segmentation, the relevant gene targets for TCF/LEF probably include engrailed, which is expressed in a narrow stripe of cells neighboring the stripe of wingless-expressing cells. A natural promoter for TCF/LEF-mediated Wnt/Wingless signaling has been identified in the homeotic gene Ultrabithorax (Ubx). The expression of Ubx in the visceral mesoderm of Drosophila depends on both wingless and decapentaplegic (dpp), which encodes a member of the transforming growth factor-␤ (TGF-␤) family of growth factors. Thus, the role of the ␤-catenin-TCF/LEF interaction in the Wnt pathway is now well established for many different signaling events.
The mechanism by which ␤-catenin/Armadillo regulates transcriptional activity of TCF/LEF is unknown, but several models have been proposed. TCF/LEF is a member of the HMG family of transcription factors, defined by the presence of a domain of a type first identified in a class of high mobility group (HMG) proteins. HMG domains are thought to have an architectural role in the control of gene expression; the idea is that, by bending DNA, they control the juxtaposition of factors bound to different sites on the gene. Indeed, there is evidence that ␤-catenin alters DNA bending induced by TCF/LEF [15] . Alternatively, ␤-catenin may be part of a trans-activating transcriptional complex that is recruited to the DNA by binding to TCF/LEF; the analysis of artificial synthetic promoters containing multiple HMG binding sites in vitro provides some evidence for this model [16] .
Analysis of the natural promoter for TCF/LEF in the Ubx gene suggests a more complicated mechanism [20] . Ubx expression depends on both Wingless and Dpp, which act through two different regions of the promoter. TCF/LEF binds to the Wingless-response sequence, which forms a stable complexes with TCF/LEF and Armadillo. The Dppresponse sequence in the Ubx promoter is adjacent to the TCF/LEF binding site, suggesting that two sets of transcriptional complexes must interact in some way to trigger expression of Ubx. A DNA bending model could explain these findings. Finally, it even remains possible that ␤-catenin regulates TCF/LEF function at a site distant from the target gene, for example by controlling the nuclear localization of TCF/LEF in response to the Wnt signal.
R444 Current Biology, Vol 7 No 7

Figure 1
Comparison of ␤-catenin-TCF/LEF-dependent signaling in Drosophila, Xenopus, and human colon cancer cells. In Drosophila: components of the Wingless pathway and their ordering were determined genetically. The accumulation of Armadillo, the ␤-catenin homologue, correlates with signaling, but preliminary findings suggest that APC is not involved in regulating Armadillo accumulation or signaling. In Xenopus: the vertebrate Wnt pathway is highly homologous to the Wingless pathway and leads to induction of the dorsal-ventral and anterior-posterior embryonic axes. All components mediate signaling in Xenopus, but upstream components shown in faint typeface may not participate in normal embryonic development. APC stimulates signal transduction through ␤-catenin-TCF/LEF in this case. In human cancer cells: APC was originally identified as a tumor suppressor in human colorectal cancer; it downregulates ␤-catenin levels and inhibits ␤-catenin-TCF/LEF-dependent signaling; moreover, ␤-catenin mutations are associated with oncogenesis in colorectal cancer and melanoma. Cadherin: this cell-cell adhesion molecule is the major ␤-catenin associated protein in the cell, and high levels of expression inhibit signal transduction by ␤-catenin. Given that the APC protein interacts with ␤-catenin, is it possible that its role as a tumor suppressor stems from its ability to regulate the Wnt pathway? Earlier findings have implicated APC in certain aspects of the Wnt pathway. In many colon tumor cell lines, expression of wild-type APC can decrease the levels of ␤-catenin by stimulating its rate of degradation [22] . Moreover, APC seems to be a very good substrate for phosphorylation by GSK [23] . In Xenopus embryos, expression of APC has similar effects to Wnts or ␤-catenin -induction of the dorsal-ventral and anterior-posterior body axes and the expression of the siamois gene [24] .
In a more recent study [6] , the role of APC in regulating gene expression in tumor cells was tested directly by assaying for TCF/LEF-dependent gene activation. A synthetic reporter gene construct having several TCF/LEF binding sites in the promoter was introduced into various colon tumor cell lines. In cells expressing severely mutated forms of APC, the reporter gene was constitutively transcribed. Importantly, when wild-type APC was introduced into the cells, it suppressed transcription of the reporter gene. Severely mutated forms of APC failed to suppress transcription of the reporter gene, and the abilities of various mutant forms of APC to suppress transcription correlated with their tumor suppressor activities in human colon cancer. In these tumor cells, therefore, APC acts to inhibit the transcriptional activity mediated by ␤-catenin and TCF/LEF, and the loss of this ability by mutations in APC accounts for the loss of its tumor suppressor activity.
APC mutations are found in most colorectal tumors, but not all of them. Do other components of this signaling pathway also contribute to colon carcinogenesis? Indeed, many colon tumor cell lines have been found to harbor specific mutations in ␤-catenin that lead to its accumulation in the cytosol and enhanced TCF/LEF-dependent transcriptional activity [7] . Interestingly, these mutations occur at specific serine residues in the amino-terminal region of ␤-catenin, which are thought to regulate ␤-catenin turnover and to be phosphorylated, directly or indirectly, by GSK [10] . Similarly, both inactivating APC mutations and activating ␤-catenin mutations occur in a large number of melanomas [8] , suggesting that the same oncogenic and tumor suppressor relationship between these two molecules is common to other types of tumor. Thus, ␤-catenin seems to act as an oncogene product that opposes the tumor suppressor function of APC within the same biochemical pathway.
The favored explanation for the biochemical mechanism underlying the tumor suppressor activity of APC is that it regulates the levels of ␤-catenin in the cytosol by controlling its degradation [5, 8, 10, 22] . In many tumor cell lines, either the loss of APC function or oncogenic ␤-catenin mutations leads to ␤-catenin accumulation in the cytosol. Also, Armadillo protein accumulates to high levels in response to the Wingless signal, suggesting an analogous mechanism. However, the role of APC in the Wnt pathway and its biochemical mechanism of action are incompletely understood. For instance, Wnts have not yet been implicated in colon cancer; hence it is conceivable that APC participates in additional signaling pathways.
Studies in Drosophila have similarly failed to reveal a role for APC in the Wingless pathway, even though they demonstrate an essential role for APC in embryogenesis [25] . Moreover, while it is clear that APC negatively regulates ␤-catenin-dependent transcription in colon tumor cell lines, as mentioned above, it has an activating activity in the Xenopus embryo, inducing siamois expression and body axis formation [24] . This suggests that APC may have a important signaling function in addition to its role in regulating ␤-catenin levels. Correspondingly, changes in the levels of ␤-catenin are not always associated with increased expression of APC [26] . As APC is a large, complex protein with a diversity of domains, several ␤-catenin binding sites, and different phosphorylation states, it would not surprising if it had diverse roles in signal transduction.
The common feature of all the signal transduction events described above is the role of ␤-catenin in regulating gene expression through the transcription factor TCF/LEF-1. The upstream mechanisms that regulate these events may be varied. Activation of the Wnt receptor may or may not be the initiating event, and in some circumstances cadherins may play a role in regulating the signaling activity of ␤-catenin. APC is clearly implicated in regulating ␤-catenin and TCF activity in some, but perhaps not all circumstances, and it may have additional signaling roles yet to be discovered. Nonetheless, it is clear that signal transduction mechanisms involving ␤-catenin are turning out to be widespread events in developmental and cancer cell biology.
